Antibody drug conjugates, or ADCs for short, are a new type of medicine that link and antibody with chemotherapy and are intended to directly target cancer cells.
ADCs are the result of many years of research and one goal of this class of medicine is to reduce the effects of chemotherapy on healthy cells.
RT @krystadawn: Lots of important topics at #ASCO13:QoL, combos,immunotherapies,nextgen antibodies...visit gene.com/asco for...
#ASCO13 MT @centenaryinst: Lovely animation communicating cancer research. RT @genentech: 2 scientists solve myste... ow.ly/lDpe6
MT @lungproject: #Healthcare professionals aren't immune to #lungcancer bias. See how you compare: bit.ly/R8VhJM #ASCO13
What one of our #Genentech scientists dreamt about before #ASCO13. Read on: bit.ly/10JmlU8 ow.ly/i/2gaUh
RT @genentech: #ASCOIQ: Proof of concept for anti-VEGF came from #Genentech data 10 yrs before #ASCO13 bit.ly/143Nf91 twitter.com/rx…
Facebook
Twitter
LinkedIn
YouTube
Pinterest
Google+